CHARLES SCHWAB INVESTMENT MANAGEMENT INC - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 87 filers reported holding CYTOSORBENTS CORP in Q4 2018. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2023$30,069
-49.2%
15,994
-3.0%
0.00%
Q2 2023$59,213
+9.9%
16,494
+3.1%
0.00%
Q1 2023$53,900
+117.4%
15,9940.0%0.00%
Q4 2022$24,791
+12.7%
15,9940.0%0.00%
Q3 2022$22,000
-38.9%
15,9940.0%0.00%
Q2 2022$36,000
-89.3%
15,994
-84.9%
0.00%
Q1 2022$338,000
-23.4%
105,693
+0.5%
0.00%
Q4 2021$441,000
-47.2%
105,131
+2.2%
0.00%
Q3 2021$836,000
+7.0%
102,878
-0.5%
0.00%
Q2 2021$781,000
-13.9%
103,396
-1.0%
0.00%
Q1 2021$907,000
+12.3%
104,392
+3.1%
0.00%
Q4 2020$808,000
+6.6%
101,279
+6.6%
0.00%
Q3 2020$758,000
-9.0%
94,994
+13.0%
0.00%
Q2 2020$833,000
+32.6%
84,080
+3.6%
0.00%
Q1 2020$628,000
+100.6%
81,1810.0%0.00%
Q4 2019$313,000
-28.4%
81,181
-6.5%
0.00%
Q3 2019$437,000
-18.8%
86,864
+6.9%
0.00%
Q2 2019$538,000
+14.7%
81,270
+31.4%
0.00%
Q1 2019$469,000
-8.2%
61,831
-2.1%
0.00%
Q4 2018$511,000
-36.6%
63,153
+1.2%
0.00%
-100.0%
Q3 2018$806,000
+18.2%
62,424
+4.4%
0.00%
Q2 2018$682,00059,7970.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q4 2018
NameSharesValueWeighting ↓
CM Management, LLC 450,000$846,0000.90%
Skylands Capital, LLC 2,944,670$5,535,9800.84%
Sargent Investment Group, LLC 1,257,048$2,363,2500.57%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 197,940$372,1270.52%
Avenir Corp 2,717,397$5,108,7060.48%
Granahan Investment Management 1,552,393$2,918,4990.10%
Seelaus Asset Management LLC 20,450$38,4460.04%
HighMark Wealth Management LLC 10,000$18,8000.02%
Key Client Fiduciary Advisors, LLC 13,000$24,4400.02%
Eudaimonia Partners, LLC 23,500$44,1800.01%
View complete list of CYTOSORBENTS CORP shareholders